EDITOR'S LETTER

EYE ON CHINA

• China approves norovirus vaccine for clinical trial
• Public hospitals in China receive increasing government funds
• Tax incentives for top talents in the Greater Bay Area
• National Health Commission of China calls for production of generic drugs
• AI offers breakthrough in cancer diagnosis
• Drug-free theranostic agent for cancer treatment
• E-healthcare innovation competition finishes in Shanghai
• Bioindustry Convention held in Guangzhou
• China’s State Council publishes new regulations on the management of human genetic resources
• Chinese institutions ranked high in Nature Index
• US$120 million joint venture in China to develop innovative cell therapies for cancer
• Digital mental health strategy in China

COLUMNS

• Are we close to finding a cure for HIV?

FEATURES

• Emerging treatments for spinal cord damage
• Dementia, Alzheimer’s, Parkinson’s – Confusions, myths and tips
• An update on Alzheimer's disease
• Integration of Traditional Chinese medicine and Western medicine in cancer treatment
• TCM’s integration into modern health system

INSIDE INDUSTRY

• National Cancer Centre Singapore launches international campaign to raise awareness about hereditary cancer
• Smart facilities for KK Women’s and Children’s Hospital
• Singapore behind China and Saudi Arabia in use of AI to improve diagnostic accuracy
• Telehealth innovation to improve access to healthcare for Singapore customers
• Epclusa made available to hepatitis C patients via Taiwan’s NHI
• Clarivate Analytics signs agreement with Melbourne Biomedical Precinct to provide comprehensive drug discovery intelligence
• Proteona releases CAR T characterisation product

BIOBOARD

ASIA-PACIFIC